Torrent Pharma’s Gujarat oncology plant inspection by USFDA concludes with zero observations

Torrent Pharma gets USFDA inspection with zero observations at its Gujarat oncology plant, Q3 FY26 profit jumps 26 percent to 635 crore, revenue up 18 percent, shares rise 1.8 percent

Leave a Reply

Your email address will not be published. Required fields are marked *